Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).
about
Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.A multi-institution phase II study of gemcitabine/cisplatin/S-1 (GCS) combination chemotherapy for patients with advanced biliary tract cancer (KHBO 1002).Phase II study of gemcitabine and S-1 combination chemotherapy in patients with metastatic biliary tract cancer.Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer.Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study.S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer.Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancerSurgery for recurrent biliary carcinoma: results for 27 recurrent casesEfficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: a meta-analysis.A meta-analysis of safety and efficacy on first-line S-1 therapy in cancer patients.Chemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials.Chemoradiation therapy with S-1 for primary squamous cell carcinoma of the rectum: report of three cases.Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT).A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report.Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition.Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.Signaling pathways as therapeutic targets in biliary tract cancer.Aggressive Hemihepatectomy Combined with Resection and Reconstruction of Middle Hepatic Vein for Intrahepatic Cholangiocarcinoma.Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy.Phase I trial of oral S-1 combined with hepatic arterial infusion of gemcitabine in unresectable biliary tract cancer.Long-term survival after multidisciplinary therapy for residual gallbladder cancer with peritoneal dissemination: a case report.The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis.Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine.Impact of Secreted Protein Acidic and Rich in Cysteine (SPARC) Expression on Prognosis After Surgical Resection for Biliary Carcinoma.A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1202).Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.Emerging drugs for biliary cancer.Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma.Concurrent radiotherapy with S-1 plus cisplatin versus concurrent radiotherapy with cisplatin alone for the treatment of locally advanced cervical carcinoma: a pilot randomised controlled trial.Phase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
P2860
Q30240120-D5ABA5C5-DF62-4A47-875E-2268B2BA0650Q33419175-0F0CED63-3B76-45FA-8562-704BCB443298Q33420043-D0F1E99A-813B-4039-8057-13D4C7E8C662Q33428545-786EA041-D515-40B7-8933-FC758EE85C77Q33438718-D1368F8B-AB0D-463C-AD7C-462AA6FD65FBQ34326711-9145791E-2E44-4BF9-B39F-2775FF0421E3Q34484514-30EB022A-E0B1-43FC-BBB3-3D76683C928BQ34779286-25F594B1-6B3E-486F-9CEF-D548925EBF38Q35149423-AD307327-F50A-43BE-B4EB-29D09FA735D1Q35535548-6D7F342F-7C63-4CC5-9D21-1C80A1FDF0B3Q35996020-DDF69AE7-7AB0-4F53-91F1-651A15D40777Q36107068-8D7DAA8E-5400-499D-8539-F0AA43E97B93Q36564168-BB7CAAB4-BA96-4462-962C-91D011ED35A0Q36949347-186E8F39-8B0F-475E-9F84-E295EBA50F46Q37640354-C76BC95E-096D-4CE5-B444-AA8F6EC85742Q37657065-20B4CD73-05B1-48BD-B4A1-779D5EF2009FQ38183813-43361902-627E-425C-A254-32441043098EQ38383198-AAFAD182-5C43-491E-815E-3A89183769EFQ38390565-26D5B21E-CCFA-4B44-A205-EA65DC2DE2FDQ38747573-6C7333CD-5E3B-4A78-9132-7C83B1CE09BDQ38844696-61145493-E586-4A05-B3DE-906E9B32D6EBQ40824695-C2BD1F84-80DA-44B6-A9B6-4423BF8AF3C8Q41479806-F47508D1-8AE1-41E7-A180-F14D6B8203EEQ42202283-80FC5B5F-97B9-4B23-92C8-44CCFB80B70BQ47139810-DA1E67B2-C6F3-4734-A779-DFAC0BA14064Q48333251-CB0D7CF7-3A68-4E20-A7FC-8810D355EE1CQ48362838-09EEECF6-511F-443E-B751-0241DB659A00Q50156486-5D9B0CE4-07E8-4637-A67E-FAD492FFAE3AQ50609881-AAB8841A-F765-4DD7-BD4D-F37B6C7798A3Q51327505-4CEDAABB-B2F2-4542-A7A6-9F4DCE945395Q52962609-9A986D20-7B15-45E9-9E24-68C726A0AA14Q53368044-1D7F253E-C359-482F-A19E-68700E8F4C3FQ57149389-691AFF22-C52B-4E10-9563-0884B624AF09
P2860
Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Randomized phase II study of g ...... ology Group trial (JCOG 0805).
@en
Randomized phase II study of g ...... Clinical Oncology Group trial
@nl
type
label
Randomized phase II study of g ...... ology Group trial (JCOG 0805).
@en
Randomized phase II study of g ...... Clinical Oncology Group trial
@nl
prefLabel
Randomized phase II study of g ...... ology Group trial (JCOG 0805).
@en
Randomized phase II study of g ...... Clinical Oncology Group trial
@nl
P2093
P2860
P356
P1433
P1476
Randomized phase II study of g ...... ology Group trial (JCOG 0805).
@en
P2093
Atsuo Takashima
Chigusa Morizane
Hiroshi Ishii
Junji Furuse
Junki Mizusawa
Makoto Ueno
Masafumi Ikeda
Narikazu Boku
Takuji Okusaka
Yasuo Hamamoto
P2860
P304
P356
10.1111/CAS.12218
P577
2013-07-25T00:00:00Z